American Society of Addiction Medicine

American Society of Addiction Medicine
Name	American Society of Addiction Medicine
Abbreviation	ASAM
Formation	1954
Type	Professional association
Headquarters	Chevy Chase, Maryland
Region served	United States
Membership	Physicians, physicians assistants, nurse practitioners

American Society of Addiction Medicine The American Society of Addiction Medicine is a professional association founded in 1954 that represents physicians and clinicians specializing in substance use disorders, and it interacts with institutions such as National Institutes of Health, Centers for Disease Control and Prevention, U.S. Food and Drug Administration, Substance Abuse and Mental Health Services Administration, and American Medical Association to influence clinical practice, policy, and research. The organization engages with stakeholders including World Health Organization, Johns Hopkins University, Harvard Medical School, Columbia University, and Mayo Clinic to develop standards, provide education, and support certification in addiction medicine.

History

Founded in 1954 by physicians connected to institutions like Boston University School of Medicine, New York University School of Medicine, University of Pennsylvania, UCLA School of Medicine, and University of California, San Francisco, the society evolved alongside developments at National Institute on Drug Abuse, White House Office of National Drug Control Policy, Royal College of Psychiatrists, American Psychiatric Association, and American Academy of Addiction Psychiatry. Over decades the group responded to major events such as the HIV/AIDS epidemic, the opioid epidemic in the United States, and policy shifts like the Controlled Substances Act and initiatives from Centers for Medicare & Medicaid Services, while collaborating with organizations including Veterans Health Administration, American Academy of Pediatrics, American College of Surgeons, and Association of American Medical Colleges.

Mission and Activities

The society’s mission interfaces with agencies and institutions such as National Quality Forum, Joint Commission, World Health Organization, National Academies of Sciences, Engineering, and Medicine, and U.S. Department of Health and Human Services to promote addiction medicine as a medical specialty, develop clinical standards, and advocate for treatment access. Activities include guideline development alongside American Psychiatric Association, policy advocacy before United States Congress, quality initiatives with Centers for Medicare & Medicaid Services, workforce development coordinated with Association of American Medical Colleges, and partnerships with research entities like National Institutes of Health, Kaiser Permanente, RAND Corporation, and Brookings Institution.

Organizational Structure and Governance

Governance mirrors structures seen at American Medical Association, American Board of Medical Specialties, American Osteopathic Association, Association of American Physicians, and Council of Medical Specialty Societies, with a board of directors, committees, and state chapters that interact with state medical boards such as the New York State Department of Health, California Medical Board, Texas Medical Board, and Florida Board of Medicine. Leadership roles include a president, executive director, and committees resembling those at American College of Physicians, American Academy of Family Physicians, Society of Critical Care Medicine, and Infectious Diseases Society of America to manage ethics, finance, education, and policy.

Clinical Guidelines and Standards

The society issues clinical guidance in collaboration with entities such as U.S. Food and Drug Administration, National Institutes of Health, American Psychiatric Association, Society of Addiction Psychiatry, and World Health Organization on topics including medication-assisted treatment, screening, and management of withdrawal. Guidelines reference medications and regulatory frameworks from Drug Enforcement Administration, Centers for Medicare & Medicaid Services, Substance Abuse and Mental Health Services Administration, and clinical research from New England Journal of Medicine, Journal of the American Medical Association, Lancet, and Addiction (journal) to shape practice standards used by hospitals like Mayo Clinic, Cleveland Clinic, Massachusetts General Hospital, and academic centers at Stanford University School of Medicine.

Education, Advocacy, and Research

Educational programs connect with academic institutions such as Harvard Medical School, Yale School of Medicine, Duke University School of Medicine, University of Michigan Medical School, and University of Washington School of Medicine and professional bodies like American Board of Preventive Medicine, American Board of Psychiatry and Neurology, American Board of Internal Medicine, and American Board of Family Medicine. Advocacy efforts engage lawmakers in the United States Congress, state legislatures, and agencies including Substance Abuse and Mental Health Services Administration and Centers for Medicare & Medicaid Services, while research collaborations have involved National Institutes of Health, National Institute on Drug Abuse, ClinicalTrials.gov, Institute of Medicine, and policy think tanks such as RAND Corporation and Urban Institute.

Membership and Certification Programs

Membership and certification pathways interact with credentialing organizations like American Board of Addiction Medicine, American Board of Medical Specialties, American Board of Psychiatry and Neurology, American Board of Family Medicine, and state licensure boards. Programs include continuing medical education tied to accreditation bodies such as the Accreditation Council for Continuing Medical Education, fellowship and residency affiliations at institutions including Johns Hopkins University School of Medicine, University of California, San Francisco, Columbia University Vagelos College of Physicians and Surgeons, and examination standards that reference tests similar to those from National Board of Medical Examiners.

Controversies and Criticism

The society has faced criticism and scrutiny in contexts involving interactions with pharmaceutical manufacturers such as Purdue Pharma, debates over medication-assisted treatment policy influenced by stakeholders including Mallinckrodt Pharmaceuticals, Indivior, Alkermes, and regulatory responses from U.S. Food and Drug Administration, with commentary appearing in outlets like The New Yorker, The New York Times, Washington Post, Stat News, and journals such as JAMA. Other criticism cites tensions with advocacy groups including Mothers Against Drunk Driving, civil rights organizations like ACLU, and professional societies such as American Psychiatric Association and American Academy of Pediatrics regarding scope of practice, conflicts of interest, and approaches to harm reduction, policy, and education.

Category:Medical associations based in the United States